{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:02:25Z","timestamp":1768892545702,"version":"3.49.0"},"reference-count":42,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,11,15]],"date-time":"2007-11-15T00:00:00Z","timestamp":1195084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2008,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>This study was performed to evaluate the antihypertensive prescribing pattern by cardiologists in outpatients attending private clinics in Kerman province, Iran during 1 year period, 2006.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Using random sampling method, 1102 prescriptions issued by cardiologists were investigated. The prescriptions of outpatients which contain at least one antihypertensive medication were separated for further analysis. Using World Health Organization (WHO) standard drug indicators, we evaluate the quality and quantity of prescriptions. The indices were compared between different sex groups by SPSS 11.5 software.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>About 39% of the patients were male. The average age of the individuals was 57.3\u2009\u00b1\u200913. The mean number of drugs per prescription was 2.84\u2009\u00b1\u20090.7, but the average of antihypertensive drugs per prescription was 1.4\u2009\u00b1\u20090.3, similarly in both sexes. The most prescribed drug class was <jats:italic>\u03b2<\/jats:italic>\u2010blockers (46.2%) followed by calcium channel blockers (CCBs) (19.2%), angiotensin\u2010converting enzyme (ACE) inhibitors (13.7%), diuretics (10.3%), angiotensin receptor blockers (ARBs) (9.2%) and other antihypertensive agents (1.5%). Most of the hypertensive patients (69.6%) were treated with a single drug while 31.4% of the patients received more than one drug. There was not a significant gender difference between the types of drug class used. Statins and acetyl salicylic acid (ASA) were prescribed as cardiovascular disease preventive drugs in 10.2 and 38% of hypertensive patients, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The mean numbers of drugs per prescription by cardiologists in Kerman province of Iran were not in agreement with WHO standard drug use indicators. Lower using rate of diuretics, statins and ASA need a comprehensive reassessment of the medical management of hypertensive patients. Copyright \u00a9 2007 John Wiley &amp; Sons, Ltd.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pds.1521","type":"journal-article","created":{"date-parts":[[2007,11,15]],"date-time":"2007-11-15T10:49:09Z","timestamp":1195123749000},"page":"180-185","source":"Crossref","is-referenced-by-count":10,"title":["The patterns of antihypertensive drug prescription by cardiologists in Kerman province of Iran, 2006"],"prefix":"10.1002","volume":"17","author":[{"given":"Gholamreza","family":"Sepehri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nooshin","family":"Talebizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Mirzazadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mottahareh","family":"Mohsenbeigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,1,31]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.542290"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0755-4982(05)84174-0"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0828-282X(07)70798-5"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2710.1998.00161.x"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-5-21"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-004-0802-8"},{"issue":"3","key":"e_1_2_1_8_2","first-page":"117","article-title":"Prescription monitoring of anti\u2010hypertensive drug utilisation at the Panjab University Health Centre in India","volume":"45","author":"Tiwari H","year":"2004","journal-title":"Singapore Med J"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.681"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.814"},{"key":"e_1_2_1_11_2","volume-title":"How to investigate drug use in health facilities (selected drug use indicators) action program on essential drugs","author":"Bimo CA","year":"1993"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1108\/09526860510612207"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92760-Q"},{"issue":"4","key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.26719\/2002.8.4-5.550","article-title":"General practitioner prescribing patterns in Babol city, Islamic Republic of Iran","volume":"8","author":"Moghadamnia AA","year":"2002","journal-title":"East Mediterr Health J"},{"issue":"4","key":"e_1_2_1_15_2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.26719\/2002.8.4-5.537","article-title":"Evaluation of drug use in Jordan using WHO prescribing indicators","volume":"8","author":"Otoom S","year":"2002","journal-title":"East Mediterr Health J"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)10327-1"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1248\/yakushi.125.821"},{"issue":"1","key":"e_1_2_1_18_2","first-page":"51","article-title":"Pharmacological gender\u2010specific medicine","volume":"54","author":"Ueno K","year":"2006","journal-title":"Rinsho Byori"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1049023X00004106"},{"issue":"21","key":"e_1_2_1_20_2","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/jama.1997.03550210043036","article-title":"Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure","volume":"278","author":"Siegel D","year":"1997","journal-title":"JAMA"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.36.4.600"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-007-9103-5"},{"issue":"3","key":"e_1_2_1_23_2","first-page":"273","article-title":"Anti\u2010hypertensive drug utilization in Continental Portugal (1999\u20132004)","volume":"25","author":"Furtado C","year":"2006","journal-title":"Rev Port Cardiol"},{"issue":"5","key":"e_1_2_1_24_2","first-page":"375","article-title":"Hypertension management in general practice in Iceland","volume":"92","author":"Jensdottir JO","year":"2006","journal-title":"Laeknabladid"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2006.05781.x"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00059-006-2829-3"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.22.1813"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1990.tb03449.x"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1497.2003.20414.x"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000229653.73128.b6"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440420033005"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000107251.49515.c2"},{"issue":"17","key":"e_1_2_1_33_2","first-page":"498","article-title":"Sex\u2010specific antihypertensive drug therapy","volume":"156","author":"Puhringer P","year":"2006","journal-title":"Wien Med Wochenschr"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199816100-00021"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000240931.90917.0c"},{"issue":"9","key":"e_1_2_1_36_2","first-page":"1358","article-title":"Cardiovascular disease risk factors in patients with confirmed cardiovascular disease","volume":"27","author":"Aghaeishahsavari M","year":"2006","journal-title":"Saudi Med J"},{"issue":"19","key":"e_1_2_1_37_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3190","article-title":"What role for statins? A review and economic model","volume":"3","author":"Ebrahim S","year":"1999","journal-title":"Health Technol Assess"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1002001"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-007-0032-4"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta11140"},{"issue":"11","key":"e_1_2_1_41_2","first-page":"820","article-title":"WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO\u2010PREMISE)","volume":"83","author":"Mendis S","year":"2005","journal-title":"Bull World Health Organ"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-5-15"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X112624"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.1521","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.1521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T21:19:09Z","timestamp":1699996749000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.1521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,31]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["10.1002\/pds.1521"],"URL":"https:\/\/doi.org\/10.1002\/pds.1521","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,31]]}}}